Jinru Wei

发表

Antidiabetic Rosiglitazone Reduces Soluble Intercellular Adhesion Molecule-1 Level in Type 2 Diabetic Patients with Coronary Artery Disease

Xian Wang, Fu-chun Zhang, Zhe Zhang, 2008, PPAR research.

Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty.

Xian Wang, Y. Guan, Guang Wang, 2005, Metabolism: clinical and experimental.

Clinical outcomes of various continued antiplatelet therapies in patients who were administered DAPT following the implantation of drug-eluting stents and developed gastrointestinal hemorrhage.

Jinru Wei, Yujie Guo, 2016, Experimental and therapeutic medicine.

Association between promoter DNA methylation and gene expression in the pathogenesis of ischemic stroke

N. Xu, Qi Huang, Xianfeng Li, 2019, Aging.

Association between polymorphisms in microRNAs and ischemic stroke in an Asian population: evidence based on 6,083 cases and 7,248 controls

Qi Huang, Gang Qin, Xianfeng Li, 2018, Clinical interventions in aging.

RUNX1 and CCL3 in Diabetes Mellitus-Related Coronary Artery Disease: A Bioinformatics Analysis

Jun Huang, Shaohua Li, Guo-Xiong Deng, 2022, International journal of general medicine.

Classifiers for Predicting Coronary Artery Disease Based on Gene Expression Profiles in Peripheral Blood Mononuclear Cells

Shaohua Li, Guo-Xiong Deng, Xiao-dong Wang, 2021, International journal of general medicine.

Comprehensive Identification of Key Genes Involved in Development of Diabetes Mellitus-Related Atherogenesis Using Weighted Gene Correlation Network Analysis

Qi Huang, D. Zou, Guo-Xiong Deng, 2020, Frontiers in Cardiovascular Medicine.

Correlation between arterial stiffness and coronary flow velocity reserve in subjects with pulse wave velocity >1400 cm/s

Jia Liu, Hongyu Wang, Jinbo Liu, 2016, Clinical and experimental hypertension.

Combination of peroxisome proliferator-activated receptor α/γ agonists may benefit type 2 diabetes patients with coronary artery disease through inhibition of inflammatory cytokine secretion

Q. Tang, Jinru Wei, Lijuan Liu, 2013, Experimental and therapeutic medicine.

Exendin-4 reverses endothelial dysfunction in mice fed a high-cholesterol diet by a GTP cyclohydrolase-1/tetrahydrobiopterin pathway

Guo-Xiong Deng, Jinru Wei, Lijuan Liu, 2018, Molecular medicine reports.

Peroxisome proliferator–activated receptor-γ agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty

Xian Wang, Y. Guan, Guang Wang, 2005 .

Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC–ACS (improving care for cardiovascular disease in China-acute coronary syndro

Xia Li, Yulan Zhao, Zhenyu Yang, 2023, European Journal of Medical Research.